Related Experiment Video

Updated: Apr 24, 2026

Author Spotlight: Intrathecal Injection – An Efficient and Reliable Delivery Method to Test the Efficacy of Gene Editing in Neonatal Mouse Brains
04:33

Author Spotlight: Intrathecal Injection – An Efficient and Reliable Delivery Method to Test the Efficacy of Gene Editing in Neonatal Mouse Brains

Published on: March 8, 2024

5.0K

Use of intrathecal baclofen in children and adolescents: interdisciplinary consensus table 2013

Steffen Berweck1, Sonnhild Lütjen1, Wolfgang Voss2

  • 1Department of Paediatric Neurology and Rehabilitation, Epilepsy Center for Children and Adults, Schön Clinic Vogtareuth, Vogtareuth, Germany.

Neuropediatrics
|September 5, 2014
PubMed

Insights

Intrathecal baclofen (ITB) offers a vital treatment for severe spasticity and dystonia in children. This consensus report details best practices for ITB therapy in pediatric movement disorders.

Area of Science:

  • Pediatric Neurology
  • Movement Disorders
  • Neurosurgery

Background:

  • Intrathecal baclofen (ITB) is increasingly used for severe pediatric spasticity and dystonia.
  • ITB application in children differs significantly from adult neurological and oncological uses.
  • A consensus on best practices is needed for this specialized pediatric application.

Purpose of the Study:

  • To establish a consensus report on best practices for intrathecal baclofen (ITB) treatment.
  • To address the specific challenges and considerations of ITB in children and adolescents with movement disorders.
  • To provide a comprehensive information base for ITB treatment options in pediatric patients.

Main Methods:

  • Development of a consensus report by an interdisciplinary group of 14 German centers.
  • Utilized a problem-oriented approach integrating theories and methods from experienced ITB users and movement disorder experts.
  • Data pooled from over 400 pediatric patients undergoing ITB treatment.

Main Results:

  • Summarized experience and supporting evidence from 14 German centers.
  • Presented findings in a tabular format for clarity and accessibility.
  • Established a current understanding of ITB treatment options for children and adolescents.

Conclusions:

  • Intrathecal baclofen (ITB) is a key therapy for severe spasticity and dystonia in pediatric patients.
  • This consensus report provides essential guidance for the optimal use of ITB in children.
  • The findings represent a significant step in standardizing ITB treatment for pediatric movement disorders.

More Related Videos

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice04:45

Lumbar Intrathecal Injection of SOD1-ASOs for Precise CNS Targeting and Predictive Efficacy in Human SOD1-G93A ALS Mice

Published on: February 24, 2026

458
Author Spotlight: Assessing Intrathecal Gene Therapy Efficacy in Juvenile Rats04:38

Author Spotlight: Assessing Intrathecal Gene Therapy Efficacy in Juvenile Rats

Published on: March 29, 2024

1.9K

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
2.8K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.5K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
2.0K
Centrally Acting Muscle Relaxants: Therapeutic Uses01:24

Centrally Acting Muscle Relaxants: Therapeutic Uses

Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
1.7K